Roxanne Tavakkol has been appointed vice president, regulatory and scientific services at TKL Research. Ms. Tavakkol will oversee the company’s regulatory services and medical writing groups and will routinely prepare advice on regulatory strategies to clients and create electronic documents for preclinical through IND, NDA and post-marketing submissions trials.
Ms. Tavakkol has more than 20 years of regulatory affairs experience with both large and small global pharmaceutical companies, most recently as vice president of regulatory affairs and quality assurance with a biotechnology company. She has secured approvals for products in all stages of development over a broad range of therapeutic areas.
“Roxanne’s leadership experience and regulatory expertise will significantly enhance our regulatory offerings,” said Bob Reardon, PhD, executive vice president and chief operating officer at TKL Research. “We are pleased to have someone with Roxanne’s depth and sophistication join us, and we anticipate that her extensive experience will benefit our clients enormously for the development of regulatory strategy and for expediting timelines.”